Skip to main content

Featured

Tax Deadline April 30: The Most Common CRA Mistakes Canadians Make — and How to Avoid Them

Missed deductions, wrong SINs, unreported side income — these are the errors that delay your refund, trigger CRA letters, and quietly cost Canadians millions every year. Here's your 2026 checklist With April 30 just days away, millions of Canadians are racing to pull together slips, receipts, and records before the Canada Revenue Agency's personal income tax deadline. But filing on time and filing  correctly  are two very different things. The CRA flags thousands of returns each year for errors that are entirely preventable — errors that delay refunds, generate costly reassessments, and sometimes result in penalties that linger for months. Whether you're a first-time filer, a seasoned DIY-er, or someone handing everything to an accountant, here are the 10 most common CRA mistakes Canadians make — and exactly how to avoid each one. 1. Misunderstanding the April 30 deadline The filing deadline for most Canadians is  April 30, 2026 . Miss it when you owe money, and you'll ...

article

Alzheimer’s vaccines get a boost from new drug approval

 

After decades of disappointment and controversy, the field of Alzheimer’s disease research has finally seen a breakthrough with the approval of the first drug that targets the underlying pathology of the condition. 

Aducanumab, a monoclonal antibody that clears amyloid plaques from the brain, was granted accelerated approval by the US Food and Drug Administration in June 2021, despite mixed results from clinical trials and objections from some experts. 

The drug’s approval has rekindled interest in other therapeutic approaches that aim to prevent or slow down the progression of Alzheimer’s, such as vaccines that stimulate the immune system to attack amyloid or tau, another protein that accumulates in the brains of people with the disease. 

Several vaccine candidates are currently in various stages of development and testing, and some researchers are optimistic that they could offer a more effective and convenient way to treat Alzheimer’s than infusions of antibodies.


Comments